Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-004314
Filing Date
2019-02-20
Accepted
2019-02-20 18:45:22
Documents
1
Period of Report
2019-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3991
  Complete submission text file 0000899243-19-004314.txt   5401
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Issuer) CIK: 0001434418 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Braunstein Scott (Reporting) CIK: 0001643875 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38584 | Film No.: 19619994